The VISIONARY trial is testing sibeprenlimab, a humanized IgG2 monoclonal antibody, in patients with IgA nephropathy, a population at high risk for kidney failure.

Chronic kidney disease or CKD, is a condition that builds over time, as a result of inappropriate kidney function. The ...

Although SGLT2 inhibitors are standard-of-care treatments for CKD, type 2 diabetes, and heart failure (HF), the drugs are underutilized in clinical practice.

We often focus on blood work for diagnostics, but urine tests hold great power mdash; sometimes uncovering things that blood alone cannot .

Please provide your email address to receive an email when new articles are posted on . Researchers identified significant differences in eGFR and measured eGFR on an individual level, according to ...

Current equations for estimated glomerular filtration rate (eGFR) that use serum creatinine or cystatin C incorporate age, sex, and race to estimate measured GFR. However, race in eGFR equations is a ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...